Treatment Study of Anti-Viral Drug

Based on promising results from a preliminary study, Roche Pharmaceutical, which manufactures the drug valganciclovir under the brand name Valcyte, has granted $1.3 million to Dr. Jose Montoya to conduct a randomized, placebo-controlled, double-blind study set to begin this quarter at Stanford University Medical Center. The study will assess the effectiveness of the drug in treating a specific subset of CFS patients.